Old Web
English
Sign In
Acemap
>
authorDetail
>
Bart van Hartingsveldt
Bart van Hartingsveldt
Janssen Pharmaceutica
Pharmacokinetics
Medicine
Pharmacodynamics
Placebo
Pharmacology
3
Papers
179
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Safety, tolerability and pharmacokinetics of a human anti-interleukin-13 monoclonal antibody (CNTO 5825) in an ascending single-dose first-in-human study
2013
British Journal of Clinical Pharmacology
Bart van Hartingsveldt
Ivo P. Nnane
Esther Bouman‐Thio
Matthew J. Loza
Alexa Piantone
Hugh M. Davis
Kevin J. Petty
Show All
Source
Cite
Save
Citations (14)
Phase I, Randomized, Double-Blind, Placebo-Controlled, Multiple Intravenous, Dose-Ascending Study of Sirukumab in Cutaneous or Systemic Lupus Erythematosus
2013
Arthritis & Rheumatism
Jacek C. Szepietowski
Surasak Nilganuwong
Anna Woźniacka
Annegret Kuhn
Filippa Nyberg
Ronald F. van Vollenhoven
Anders Bengtsson
Adam Reich
Dick E. de Vries
Bart van Hartingsveldt
Don Robinson
Robert Gordon
Benjamin Hsu
Show All
Source
Cite
Save
Citations (84)
Pharmacokinetics, pharmacodynamics and safety of a human anti-IL-6 monoclonal antibody (sirukumab) in healthy subjects in a first-in-human study
2011
British Journal of Clinical Pharmacology
Zhenhua Xu
Esther Bouman‐Thio
Craig Comisar
Bart Frederick
Bart van Hartingsveldt
Joseph C. Marini
Hugh M. Davis
Honghui Zhou
Show All
Source
Cite
Save
Citations (81)
1